Dual influenza subtype positivity is linked to more severe pneumonia, but is it true co-infection or a dataset artifact?

Summary This retrospective single-center study (Guangyuan, China, September 2024–March 2025) linked clinical and BALF targeted-NGS pathogen data in 97 adults hospitalized with influenza-associated CAP. There were 51 H1N1 mono-positive and 46 H1N1/H3N2 dual-positive (all H3N2-positive patients were also H1N1-positive). Dual positivity was associated with lower PaO2/FiO2 (244 vs 294; p=0.018), higher IL-6 and CRP, more invasive ventilation (23.9% vs 7.8%; p=0.047), more fungal co-detection (47.8% vs 25.5%, driven by Pneumocystis jirovecii), and higher composite adverse disposition (death or discharge against medical advice: 26.1% vs 3.9%; OR 8.65, p=0.003). The association attenuated after adjusting for PaO2/FiO2 (OR 4.38; p=0.147), identifying hypoxemia as the principal correlate of excess risk. Comment: Hen or egg? Hypothesis-generating only: n=97, 14 events, no H3N2-mono comparator, no viral-load data confirming true co-infection. The higher rate of fungal/Pneumocystis co-detection suggests an alternative explanation: undiagnosed immunosuppression may predispose patients to both dual-subtype detection and greater illness severity, rather than dual positivity itself...